VHCP Management as of June 30, 2014
Portfolio Holdings for VHCP Management
VHCP Management holds 17 positions in its portfolio as reported in the June 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gw Pharmaceuticals Plc ads | 17.9 | $34M | 312k | 107.29 | |
| Anacor Pharmaceuticals In | 14.7 | $27M | 1.5M | 17.73 | |
| BioCryst Pharmaceuticals (BCRX) | 11.9 | $22M | 1.7M | 12.75 | |
| Dyax | 10.3 | $19M | 2.0M | 9.60 | |
| Heron Therapeutics (HRTX) | 7.2 | $14M | 1.1M | 12.32 | |
| Dbv Technologies (DBVTF) | 6.7 | $13M | 480k | 25.94 | |
| Keryx Biopharmaceuticals | 5.8 | $11M | 700k | 15.38 | |
| Zafgen | 5.7 | $11M | 542k | 19.78 | |
| Flamel Technologies | 4.0 | $7.5M | 500k | 15.00 | |
| Radius Health | 3.6 | $6.8M | 525k | 13.00 | |
| Ocera Therapeutics | 2.9 | $5.4M | 704k | 7.64 | |
| Ohr Pharmaceutical | 2.4 | $4.5M | 477k | 9.51 | |
| Neurocrine Biosciences (NBIX) | 2.4 | $4.5M | 304k | 14.83 | |
| Therapeuticsmd | 2.0 | $3.7M | 847k | 4.42 | |
| Zs Pharma | 1.5 | $2.9M | 100k | 28.75 | |
| Alexza Pharmaceuticals | 0.6 | $1.1M | 248k | 4.57 | |
| Lipocine | 0.5 | $867k | 142k | 6.10 |
